Quantcast

Apothedermâ„¢ Stretch Mark Cream Featured in Backstage Bag Celebrity Baby Bags

November 17, 2011

Apothederm announces the inclusion of their Stretch Mark Cream in Backstage Bag Celebrity Baby Bags. These VIP gift bags contain luxury items to celebrity parents with babies and small children.

Bothell, WA (PRWEB) November 16, 2011

Apothederm announces the inclusion of their Stretch Mark Cream in Backstage Bag Celebrity Baby Bags. These VIP gift bags contain luxury items to celebrity parents with babies and small children.

âœWeâre very excited to be partnering with Backstage Bag Celebrity Baby Bags,â said Robin Carmichael, Chief Operating Officer of Helix BioMedix. âœOur Stretch Mark Cream is a popular item with our customers and we are thrilled to be sharing it with celebrity mothers.â

The bags are produced three times and year and the recipients of the November 2011 edition will include:

January Jones

Selma Blair

Jenna Fischer

Kimberly Stewart

Denise Richards

Alicia Silverstone

Victoria Beckham

Ali Landry

Paul & Erin Stanley

Tori Spelling

Evangeline Lilly

Tia Mowry

Emily Deschanel

Mary McCormack

Marla Sokoloff

Apothederm Stretch Mark Cream features SmartPeptide̢Ң technology. It provides an effective, clinical proven solution for weakened tissue and stressed skin due to growth spurts, rapid weight gain and post-pregnancy stretching. Inspired by nature and powered by science, the cream optimally blends four natural emollients: shea butter, cocoa butter, olive oil and highly moisturizing meadowfoam seed oil for a silky, fast-absorbing formulation. These emollients are blended with the power-packed action of their exclusive, patented heptapeptide-7 along with resveratrol, licorice extract, brightening amino acids, algae extract and other advanced ingredients that work to fade the appearance of stretch marks, nourish skin, even skin tone, improve skin texture and smoothness and protect skin to help prevent future stretch marks.

About Apothederm Products:

Backed by 20 years of research and development in the skin science, the Company̢s SmartPeptides̢Ң have been developed through years of research by Helix BioMedix. This technology is a new generation of patented, bioactive peptides that mimic precise amino acid sequences of the skin̢s own natural protect and restore functions. SmartPeptides̢Ң are highly precise molecules that work to target specific skin problems, such as the appearance of fine lines and wrinkles, loss of elasticity, loss of firmness and definition, appearance of darkened areas or general unevenness of skin tone, rough texture and thinning of the skin.

About Backstage Bag: A leader in luxury celebrity gift bags, Backstage Bag has been featured in numerous magazines and television outlets including the latest feature in the November issue of Pregnancy and Newborn. Contact amy(at)backstagebag(dot)com or backstagebags(at)yahoo(dot)com or visit http://www.backstagebag.com for more information.

Helix BioMedix understands that what consumers put in their bodies and on their skin is important and their products are formulated with that in mind. Apothederm products are dermatologist tested. For more information on Apothederm please contact Jessica Burfield at Libra Design and Media, 608âÂ577-9337, or jessica(at)libradesignandmedia(dot)com.

Helix BioMedix is a SeattleâÂbased dermatology biotech company that develops the most advanced bioactive peptides. With more than 20 years of research and development, Helix BioMedix has patents on hundreds of products and thousands of peptides some of which are used leading skin care companies around the world. Apothederm by Helix BioMedix offers the most technologically advanced ways to topically treat consumerâs everyday skin concerns. The Company delivers highâÂtech skin care and their effective formulations treat underlying conditions to restore and maintain the health and appearance of skin. Apothederm products can be found online at http://apothederm.com/.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/11/prweb8973063.htm


Source: prweb



comments powered by Disqus